You are here: Molecules\MMP-9\References:

References to MMP-9 (Matrix metalloproteinase-9, 92 kDa type IV collagenase, 92 kDa gelatinase, Gelatinase B)

  • Dwek RA, Rudd PM, Nelissen I, Dubois B, Van den Steen PE, Opdenakker G. Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9). Crit Rev Biochem Mol Biol. 2002 Dec;37 (6):375-536
  • Mobashery S, Meroueh SO, Chvyrkova I, Toth M, Fridman R. Cell surface association of matrix metalloproteinase-9 (gelatinase B). Cancer Metastasis Rev. 2003 Jun-Sep;22 (2-3):153-66
  • Sellebjerg F, Sorensen TL. Chemokines and matrix metalloproteinase-9 in leukocyte recruitment to the central nervous system. Brain Res Bull. 2003 Aug 15;61 (3):347-55
  • Nelissen I, Opdenakker G, Van Damme J. Functional roles and therapeutic targeting of gelatinase B and chemokines in multiple sclerosis. Lancet Neurol. 2003 Dec;2 (12):747-56
  • Masure S, Van Coillie E, Nelissen I, Dubois B, Van den Steen PE, Opdenakker G, Proost P, Van Damme J. Gelatinase B functions as regulator and effector in leukocyte biology. J Leukoc Biol. 2001 Jun;69 (6):851-9
  • Turpeenniemi-Hujanen T. Gelatinases (MMP-2 and -9) and their natural inhibitors as prognostic indicators in solid cancers. Biochimie. 2005 Mar-Apr;87 (3-4):287-97
  • Lagente V, Boichot E, Belleguic C, Corbel M. Involvement of gelatinases (MMP-2 and MMP-9) in the development of airway inflammation and pulmonary fibrosis. Cell Biol Toxicol. 2002;18 (1):51-61
  • Smits JF, Cleutjens JP, Creemers EE, Daemen MJ. Matrix metalloproteinase inhibition after myocardial infarction: a new approach to prevent heart failure?. Circ Res. 2001 Aug 3;89 (3):201-10
  • Squire IB, Thompson MM. Matrix metalloproteinase-9 expression after myocardial infarction: physiological or pathological?. Cardiovasc Res. 2002 Jun;54 (3):495-8
  • Senior RM, Atkinson JJ. Matrix metalloproteinase-9 in lung remodeling. Am J Respir Cell Mol Biol. 2003 Jan;28 (1):12-24
  • Kanayama H. Matrix metalloproteinases and bladder cancer. J Med Invest. 2001 Feb;48 (1-2):31-43
  • Van Muijen GN, Westphal JR, Hofmann UB, Ruiter DJ. Matrix metalloproteinases in human melanoma. J Invest Dermatol. 2000 Sep;115 (3):337-44
  • Ohbayashi H. Matrix metalloproteinases in lung diseases. Curr Protein Pept Sci. 2002 Aug;3 (4):409-21
  • Catt KJ, Shah BH. Matrix metalloproteinases in reproductive endocrinology. Trends Endocrinol Metab. 2004 Mar;15 (2):47-9
  • van Kempen LC, Coussens LM. MMP9 potentiates pulmonary metastasis formation. Cancer Cell. 2002 Oct;2 (4):251-2
  • Chakraborti T, Mandal A, Das S, Mandal M, Chakraborti S. Regulation of matrix metalloproteinases: an overview. Mol Cell Biochem. 2003 Nov;253 (1-2):269-85
  • Vacirca J, Zucker S. Role of matrix metalloproteinases (MMPs) in colorectal cancer. Cancer Metastasis Rev. 2004 Jan-Jun;23 (1-2):101-17
  • Jarjour NN, Kelly EA. Role of matrix metalloproteinases in asthma. Curr Opin Pulm Med. 2003 Jan;9 (1):28-33
  • Lopez DM, Iragavarapu-Charyulu V, Owen JL. T cell-derived matrix metalloproteinase-9 in breast cancer: friend or foe?. Breast Dis. 2004;20:145-53
  • de Bont ES, Kamps WA, Fraaije MW, Vellenga E, Klein G. The possible role of matrix metalloproteinase (MMP)-2 and MMP-9 in cancer, e.g. acute leukemia. Crit Rev Oncol Hematol. 2004 May;50 (2):87-100
  • Yamashita J, Okada Y, Nakada M. The role of matrix metalloproteinases in glioma invasion. Front Biosci. 2003 Jan 1;8:e261-9
  • Tuszynski G, John A. The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis. Pathol Oncol Res. 2001;7 (1):14-23


Shopping cart

Your cart is empty.